Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Gallman Cari. Insider active across 1 company, notably Bristol Myers Squibb Co. Aggregated, 9 reports have been recorded. Activity tracked since 10 March 2024. The latest transaction was disclosed on 1 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
Gallman Cari is a declarant linked to Bristol Myers Squibb Co, where he is EVP, Corporate Affairs. The 4 filings on record cover the period from 2024-03-12 to 2025-03-12, and, within this recent sample, the buy and sell amounts are both 0 €, with transactions mainly of the Levée d'options type.